Nello Mainolfi - 08 Jul 2021 Form 4 Insider Report for Kymera Therapeutics, Inc. (KYMR)

Role: Chief Executive Officer, Director
Signature: /s/ Bruce Jacobs, as Attorney-in-Fact
Issuer symbol: KYMR
Transactions as of: 08 Jul 2021
Net transactions value: -$2,285,788
Form type: 4
Filing time: 09 Jul 2021, 16:30:31 UTC
Previous filing: 14 Jun 2021
Next filing: 28 Jul 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KYMR	Common Stock	Options Exercise	$99,840	+48,000	+11%	$2.08^*	500,199	08 Jul 2021	Direct
transaction	KYMR	Common Stock	Sale	$846,854	-17,230	-3.4%	$49.15	482,969	08 Jul 2021	Direct	F1, F2
transaction	KYMR	Common Stock	Sale	$1,183,333	-23,803	-4.9%	$49.71	459,166	08 Jul 2021	Direct	F1, F3
transaction	KYMR	Common Stock	Sale	$324,717	-6,372	-1.4%	$50.96	452,794	08 Jul 2021	Direct	F1, F4
transaction	KYMR	Common Stock	Sale	$30,724	-595	-0.13%	$51.64	452,199	08 Jul 2021	Direct	F1, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KYMR	Stock Option (Right to Buy)	Options Exercise	$0	-48,000	-27%	$0.000000	126,725	08 Jul 2021	Common Stock	48,000	$2.08	Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on November 6, 2020.
F2	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.44 to $49.42. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F3	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $49.44 to $50.42. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F4	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.45 to $51.44. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F5	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.60 to $51.71. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F6	The shares underlying this stock option shall vest upon the achievement of specified performance-based milestones.